Search Results for: Samsung
Asia-Pacific CDMO
Samsung Biologics Inks CDMO Deal with Enzolytics on HIV and COVID-19 Antibodies
2021-10-08
Trials & Approvals
FDA Approves Samsung Bioepis and Biogen’s Lucentis Biosimilar
2021-09-22
M&A Gene Therapy
Novartis Expands Optogenetics Portfolio By Acquiring Swiss Startup for an Undisclosed Amount
2021-09-21
Asia-Pacific Biosimilar
Samsung Bioepis Presents 5-Year Follow-up Results on Trastuzumab Biosimilar at ESMO 2021
2021-09-13
Asia-Pacific
South Korea’s Boryung Launches Avastin Biosimilar Developed by Samsung Bioepis
2021-09-02
Biosimilar
Addressing The Global Need for Biosimilars: Current Trends, Expectations and Real World Experiences
2021-08-26
COVID-19 mRNA Vaccine
South Korea Seeks Global Partners for Upping COVID-19 Vaccine Production
2021-06-18
Manufacturing
Korea’s Local Pharmas Unite to Strengthen mRNA Vaccine Production
2021-06-03
Manufacturing mRNA Vaccine
Samsung Biologics to Produce mRNA Vaccine Ingredients in Songdo Facility
2021-06-01
COVID-19 mRNA Vaccine
COVID-19: Moderna Enters Manufacturing Agreement with Samsung Biologics after Vaccine Bags Conditional Nod in South Korea
2021-05-23
Cancer
Samsung Biologics Renews Manufacturing Deal to Expand Production of TG Therapeutics’ Cancer Drug
2021-04-27
Multiomics
ROSALIND Partners with Two Korean Biotechs to Expand Cancer Research in Asia
2021-04-16
Anti-TNF
Korea Made Humira Biosimilar Begins Sales in Australia, Marks its Presence in Third Overseas Market
2021-03-31
M&A Healthcare
Merck Spinoff Expands Healthcare Business by Investing $240 Million in Acquiring Alydia Health
2021-03-31
Two South Korean Companies Look to Capture the Biosimilars Market Worth Billions
2020-12-01
1 2 3 4 5
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top